Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
A Double-blind, Vehicle-controlled Study to Assess the Safety, Tolerability, and Efficacy of
Three Weeks of Daily Dermal Application of MRX-6 or steroid on the Treatment of Mild to
Moderate Allergic Contact Dermatitis of the Hand and Forearm.
Total number of patients: up to 80.